Skip to main content
logo
Cue Biopharma, Inc. (CUE)
NASDAQ: CUE · Real-Time Price · USD
20.78
-0.67 (-3.12%)
Oct 30, 2026, 11:32 AM EDT - Market open

Cue Biopharma Ratios and Metrics

Millions USD. Fiscal year is Jan - Dec.

Total Valuation

Fiscal Year
CurrentFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Oct '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Market Capitalization
1512869119123359
Market Cap Growth
154.99%-59.65%-42.03%-2.89%-65.85%-5.17%
Enterprise Value
13714468183295
Last Close Price
21.459.1632.7079.2085.50339.30

Price Ratios

Fiscal Year
CurrentFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Oct '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
PS Ratio
4.141.017.4421.7098.5324.04
PB Ratio
48.561.053.953.211.875.49
P/TBV Ratio
67.461.053.953.211.875.49

EV Ratios

Fiscal Year
CurrentFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Oct '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
EV/Sales Ratio
3.760.504.9714.7266.7519.76

Financial Efficiency

Fiscal Year
CurrentFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Oct '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Debt / Equity Ratio
1.330.160.510.400.290.15
Net Debt / Equity Ratio
-6.21-0.91-0.83-0.92-0.87-0.83
Net Debt / EBITDA Ratio
0.150.940.350.661.081.28
Net Debt / FCF Ratio
0.291.100.400.851.361.37
Asset Turnover
1.060.740.200.070.010.16
Quick Ratio
1.072.641.782.966.615.28
Current Ratio
1.252.741.843.016.685.35
Return on Equity (ROE)
-1603.48%-121.11%-149.03%-98.73%-80.82%-61.16%
Return on Assets (ROA)
-172.66%-44.56%-55.47%-42.53%-38.29%-29.87%
Return on Capital Employed (ROCE)
-1039.60%-92.30%-224.80%-117.00%-67.10%-61.90%

Yields

Fiscal Year
CurrentFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Oct '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Earnings Yield
-174.31%-95.47%-58.90%-42.59%-43.21%-12.29%
FCF Yield
-32.20%-78.47%-52.71%-33.55%-34.22%-11.07%
Buyback Yield / Dilution
-84.06%-68.18%-23.11%-28.35%-13.95%-9.05%
SEC Filings: 10-K · 10-Q